logo-loader

Small Cap Wrap - AMRYT PHARMA PLC; BLOCK ENERGY; BLUEJAY MINING and more...

What’s cooking in the IPO kitchen?;Main Market Standard; and Main Market premium

Small Cap Wrap - AMRYT PHARMA PLC; BLOCK ENERGY; BLUEJAY MINING and more...

Set Menu

AIM:

Total number of AIM Companies (Incl Susp):

880*

Total number of AIM Companies trading:

795*

*as at close of business 16 September 2019

 

Standard List**  of Main Market:

Total number of Standard List Companies

(Incl Susp):

166*

Total number of Standard List Companies trading:

144*

*as at close of business 16 September 2019

 

NEX Growth Market:

Total number of NEX Growth Market Companies (Incl Susp):

89*

Total number of NEX Growth Market Companies trading:

87*               

*as at close of business 16 September 2019

*A corporate client of Hybridan LLP

**  Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity

 

Dish of the day

No Joiners Today

Off the menu

No Leavers Today

What’s cooking in the IPO kitchen?

AIM

AMRYT PHARMA PLC(LON:AMYT— a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases have raised $60m before expenses and will relist on the AIM Market on the 25/09/2019 

Main Market Standard

VAALCO Energy, Inc. (NYSE: EGY), an independent energy company focused on development and production assets in West Africa, today announces its formal intention to seek a Standard Listing on the Main Market of London Stock Exchange ("LSE"), to complement its existing Listing on the New York Stock Exchange. 

Kaspi.kz, the largest Payments, Marketplace and Fintech Ecosystem in Kazakhstan with a leading market share in each of its key products and services, announces today the expected publication of a registration document that has been submitted for approval to the FCA and its potential intention, subject to market conditions, to undertake an initial public offering .

Main Market premium

Registration document approved for Helios Towers. The Group provides essential network services, flexible infrastructure solutions and reliable power supply to mobile network operators  in five African growth economies. Revenue increased 7 per cent. year-on-year to US$191m (H1 2018: US$178m), with Adjusted EBITDA up 15 per cent. year-on-year at US$99m (H1 2018: US$86m) for the six months ended 30 June 2019.

 

Banquet Buffet

TMT Investments* (LON:TMT) 4.17p £98m

TMT Investments PLC, the venture capital company investing in high-growth, technology companies across a number of core specialist sectors, announced its unaudited interim results for the half-year ended 30 June 2019.

Highlights

NAV per share of US$3.66 (uplift of 18.45% from US$3.09 as of 31 December 2018)

US$29.5m in positive revaluations from Backblaze, Taxify, PandaDoc, Workiz and eAgronom

Many portfolio companies continue to experience rapid growth, with three new investments made during the period

Post period end

Following profitable cash exit from Wrike, Inc. at the end of 2018, the Company declared and paid a special dividend of US$5.8m (US$0.20 per ordinary share) during July 2019

Completed a further four new investments and remain well funded to continue to expand and support the Company's investment portfolio

 

Karelian Diamond Res. (LON:KDR) 3.2p £1.24m

Karelian Diamonds announced that, further to the announcement released by the Company on 15 July 2019, the Company has appointed Howard Bird as a non-executive director of the Company with immediate effect. Mr. Bird will also continue in his role as a geo-science consultant to the Company.

Mr. Howard Bird is an internationally experienced Professional Geoscientist (diamonds, gold, platinum and base metals) and has over 30 years’ diverse junior and senior mining company exploration, development and mining experience, including over 15 years at senior executive management level.

Mr. Bird has a strong background in both European and North American marketing, capital financings, mergers and acquisitions, and joint-ventures. He has a proven track record contributing to significant company value added growth with grassroots exploration discovery success, development and production of highly profitable kimberlite diamond deposits.

 

MS International (LON:MSI) 197p £33m

“It is most disappointing to report, though not surprising, that the Company is not immune to the negative impact of the widespread global economic uncertainty. As reported in the last Chairman's results statement, these are proving to be 'interesting times'.

Across the four divisions we are seeing a progressive reduction in demand for both our products and services. Of particular significance is the significant slowdown and delays in the awarding of UK defence related contracts, following requests for tender submissions. Delays in anticipated contract awards, by their very nature, engender costly uncertainty and concern particularly when being the only genuinely qualified potential supplier.  Unfortunately, responding to customer invitations to submit a comprehensive tender and then failing to award a contract is becoming an increasingly frustrating feature of our domestic defence business.”

 

Arix Bioscience (LON:ARIX)  119.9p £162.53m

Updates from portfolio company Amplyx Pharmaceuticals. Positive preliminary data from ongoing APX 001 (fosmanogepix) Phase 2 study in candidemia. The Data Review Committee (DRC) and Data Safety Monitoring Board (DSMB) have reviewed data from the first ten patients. The DRC adjudicated that fosmanogepix demonstrated a high level of treatment success at the end of study drug treatment. Treatment success is defined as clearance of Candida from the blood, patient is alive following treatment, and having received no other systemic antifungal therapies following initiation of study drug. The DSMB recommended that the study continue according to the protocol. Amplyx also announced that it has executed an exclusive worldwide license agreement with Novartis uynder which Amplyx has acquired the rights to the Phase 2 anti-BK virus (BKV) monoclonal antibody, MAU868, for the treatment and prevention of BKKV disease. Capital mkts day 3 Oct https://arixbioscience.com/events/oncology-portfolio-spotlight

 

Block Energy (LON:BLOE) 7.45p £29.32m

Block Energy PLC, the exploration and production company focused on the Republic of Georgia, announced that Mr William McAvock, FCCA, has been appointed as Chief Financial Officer and a Director of the Company's Board, having previously acted as Finance Manager since 13 May 2019.

 

St James House (LON:SJH) 58p £1.81m

The Board of Directors of the Company to provides the following trading statement and update on recent developments.

Payments Division

The new corporate client for the pre-paid card programme announced on 9 July 2019, continue with the production of their cards, however this is behind the original timetable as designs for cards and related services are waiting for card scheme commercial approvals.  To date, no cards had been issued to end-users under this programme.

Good progress has been made with the roll out of new services for EUR, GBP and USD based accounts beginning the week commencing 16 September.  

Play Division

The Lottery business remains on target to make a positive operating contribution to the Group for the second half of the year to 31 January 2020.  There is no update for PPS Blockchain Ltd, the lottery joint venture announced on 8 March 2019.  

 

Shearwater Group (LON:SWG) 1.82p £40.34m

Shearwater Group PLC, the organisational resilience group, announces that its group company, Pentest has secured a one-year contract with a global technology corporation worth in excess of US$1m. At the same time, Xcina Consulting, another Shearwater group company has also signed a 'Master Consulting Agreement' and become a preferred supplier to the same organisation.

Under the terms of the contract, Pentest will deliver a framework for the provision of vulnerability assessment and penetration testing services to the organisation. This will form a key function within the organisation's global cloud technology infrastructure.

Through penetration testing, Pentest will perform an in-depth investigation into the organisation's resilience with the aim of uncovering any IT security vulnerabilities.

 

Bluejay Mining (LON:JAY) 9.02p £77m

Bluejay Mining plc, the AIM and FSE listed Greenland focused company, announced the formal lodgement of its exploitation licence application for the Dundas Ilmenite Project to the Mineral Licence and Safety Authority, Greenland.

 

Aquis Exchange (LON:AQX) 475p £m

HY Jun 19 results.

Revenue increased 165% to £3.4m

EBITDA loss of £0.16m (HY 20183: £1.6m loss)

Cash and cash equivalents at 30 June 2019 of £11.2m

Trading Members on Aquis Exchange grew from 27 to 29 during the six month period

Market share of overall pan-European continuous trading grew over the period to 4.8% 2Q19 (3.8% 4Q18), with the share of available liquidity also increasing

Through its French subsidiary, Aquis became the first MTF to achieve dual-trading status in European equities, in preparation for Brexit

Successful deployment of several technology implementations

Post period ·           Agreed acquisition of the NEX Exchange subject to FCA approval, marking entry into Primary Listings

Current trading in line with market expectations for FY19

 

Arc Minerals (LON:ARCM) 3.17p £22.75m

Arc Minerals Limited provides an update on the recently completed infill soil sampling programs over the Lumbeta and Muswema target areas located within the 872 km2 Zamsort and Zaco exploration license areas in the Domes Region of the North Western Province in Zambia

Highlights:

Analysis of 8,100 soil samples at both target areas completed

Up to 1,793ppm Cu analysed in the soils at Muswema

Circa 4km long soil anomaly confirmed at both Muswema and Lumbeta

Additional anomalies result in both target areas split into a further three zones

Drill rigs en route to each target and maiden drill programme to commence imminently

Drilling continues at Cheyeza where visible sulphide mineralisation has just been observed

New targets confirm a larger mineralised system

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Amryt Pharma PLC named herein, including the promotion by the Company of Amryt Pharma PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Rainbow Rare Earths hits reset button as it moves towards more efficient ...

Proactive London's Andrew Scott sits down with the new CEO of Rainbow Rare Earths Ltd (LON:RBW) George Bennett. He describes the 12 months to June 2019 as a 'tough year' for Rainbow but have been able to learn a lot about the project and are now adapting the way they operate. Bennett adds...

2 days, 13 hours ago

8 min read